{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:59:03Z","timestamp":1793271543446,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.semarthrit.2021.06.006","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T10:47:37Z","timestamp":1624099657000},"page":"880-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Axial involvement in psoriatic arthritis: An update for rheumatologists"],"prefix":"10.1016","volume":"51","author":[{"given":"Denis","family":"Poddubnyy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak R.","family":"Jadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Mease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semarthrit.2021.06.006_bib0001","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10089","key":"10.1016\/j.semarthrit.2021.06.006_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med (Lond)"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.06.006_bib0004","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.06.006_bib0006","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0007","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.06.006_bib0008","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3899\/jrheum.130459","article-title":"Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting","volume":"40","author":"Mease","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fmed.2018.00246","article-title":"Classification and outcome measures for psoriatic arthritis","volume":"5","author":"Leung","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101669","article-title":"Diagnosis, classification and assessment","author":"Antony","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0011","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.semarthrit.2021.03.007","article-title":"Axial disease in psoriatic arthritis: the presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort","volume":"51","author":"Feld","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-021-00999-8","article-title":"Axial psoriatic arthritis","volume":"23","author":"Gladman","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0013","first-page":"974","article-title":"Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis","volume":"32","author":"Taylor","year":"2005","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0014","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11926-007-0074-2","article-title":"Axial disease in psoriatic arthritis","volume":"9","author":"Gladman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.091059","article-title":"Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis","volume":"37","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/482691","article-title":"Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis","author":"Queiro","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0017","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2012-201357","article-title":"Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis","volume":"72","author":"Eder","year":"2013","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"10.1016\/j.semarthrit.2021.06.006_bib0018","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s10067-018-4173-4","article-title":"Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life","volume":"37","author":"Aydin","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.06.006_bib0019","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.171094","article-title":"Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry","volume":"45","author":"Mease","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0020","first-page":"1","article-title":"The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis","author":"Nas","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0021","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/2193-1801-3-759","article-title":"Simple clinical indicators for early psoriatic arthritis detection","volume":"3","author":"Caso","year":"2014","journal-title":"Springerplus"},{"issue":"10","key":"10.1016\/j.semarthrit.2021.06.006_bib0022","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/ard.2011.151167","article-title":"Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0023","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.rdc.2012.08.014","article-title":"Inflammatory back pain","volume":"38","author":"Burgos-Vargas","year":"2012","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0024","series-title":"Inflammatory back pain","year":"2020"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.06.006_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/09546634.2019.1605142","article-title":"Psoriatic arthritis for dermatologists.","volume":"31","author":"Gottlieb","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40744-020-00234-3","article-title":"Evaluating inflammatory versus mechanical back pain in individuals with psoriatic arthritis: a review of the literature","volume":"7","author":"Grinnell-Merrick","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.06.006_bib0027","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/ard.2011.152975","article-title":"HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis","volume":"70","author":"Chung","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3899\/jrheum.200129","article-title":"GRAPPA 2019 project report","volume":"96","author":"Goel","year":"2020","journal-title":"J Rheumatol Suppl"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0029","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/rheumatology\/kez629","article-title":"Axial disease in psoriatic arthritis","volume":"59","author":"Helliwell","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0030","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.201672","article-title":"Updates on axial psoriatic arthritis from the 2020 GRAPPA annual meeting","author":"Gladman","year":"2021","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0031","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ard.20.1.36","article-title":"Quantitative and qualitative analysis of joint stiffness in normal subjects and in patients with connective tissue diseases","volume":"20","author":"Wright","year":"1961","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.06.006_bib0032","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0033","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.rdc.2020.01.009","article-title":"Axial psoriatic arthritis: a distinct clinical entity in search of a definition","volume":"46","author":"Michelena","year":"2020","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0034","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/annrheumdis-2019-eular.2932","article-title":"Secukinumab improves axial manifestations in patients with psoriatic arthritis and inadequate response to NSAIDs: primary analysis of the MAXIMISE trial","volume":"78","author":"Baraliakos","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.06.006_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/annrheumdis-2020-eular.638","article-title":"Secukinumab improves clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations with inadequate response to NSAIDs: week 52 results from the MAXIMISE trial","volume":"79","author":"Baraliakos","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"suppl 1","key":"10.1016\/j.semarthrit.2021.06.006_bib0036","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/annrheumdis-2020-eular.474","volume":"79","author":"Helliwell","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0038","doi-asserted-by":"crossref","unstructured":"Ogdie A., Blachley T., Glynn M., et\u00a0al. Comparison of patients with psoriatic arthritis (PsA) and investigator-defined axial PsA to patients with PsA and elevated patient-reported spine pain: findings from the Corrona Psoriatic Arthritis\/Spondyloarthritis (PsA\/SpA) Registry. Oral presentation at: annual European Congress of Rheumatology; June 3-6, 2020. Abstract OP0052.","DOI":"10.1136\/annrheumdis-2020-eular.1072"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.06.006_bib0039","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/acr.23189","article-title":"Sensitivity and Specificity of Radiographic Scoring Instruments for Detecting Change in Axial Psoriatic Arthritis","volume":"69","author":"Ibrahim","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.semarthrit.2021.06.006_bib0040","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/annrheumdis-2018-213334","article-title":"Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis","volume":"77","author":"Yap","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.06.006_bib0041","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2018-214583","article-title":"Inflammatory back pain criteria perform well in subset of patients with active axial psoriatic arthritis but not among patients with established axial disease","volume":"78","author":"Haroon","year":"2019","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0042","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.20017","article-title":"Validity of the Bath Ankylosing Spondylitis Disease Activity Index for the evaluation of disease activity in axial psoriatic arthritis.","volume":"62","author":"Fern\u00e1ndez-Sueiro","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0043","first-page":"136","article-title":"Good clinimetric alignment between remission and a low impact of disease in patients with axial psoriatic arthritis","volume":"38","author":"Queiro","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2021.06.006_bib0044","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3899\/jrheum.150083","article-title":"Psoriatic arthritis mutilans: characteristics and natural radiographic history","volume":"42","author":"Jadon","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.berh.2018.09.002","article-title":"Comorbidities in spondyloarthritis including psoriatic arthritis","volume":"32","author":"Molt\u00f3","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0046","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1590\/S0365-05962012000600009","article-title":"Psoriasis and uveitis: a literature review","volume":"87","author":"Fraga","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0047","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/rheumatology\/kev296","article-title":"HLA-B27 and psoriatic disease: a modern view of an old relationship","volume":"55","author":"Queiro","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0048","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BOR.0000000000000136","article-title":"What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?","volume":"27","author":"Eder","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0049","first-page":"270","article-title":"Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis","volume":"35","author":"Haroon","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.058453","article-title":"Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?","volume":"65","author":"Gladman","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0051","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/keg475","article-title":"Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101670","article-title":"Clinical features of psoriatic arthritis","author":"Kishimoto","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0053","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol."},{"issue":"5","key":"10.1016\/j.semarthrit.2021.06.006_bib0054","first-page":"24","article-title":"Imaging in peripheral and axial psoriatic arthritis: contributions to diagnosis, follow-up, prognosis and knowledge of pathogenesis","volume":"36","author":"Felbo","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2021.06.006_bib0055","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/art.38050","article-title":"Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B27","volume":"65","author":"Castillo-Gallego","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0056","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/03009742.2012.739637","article-title":"Erosive discovertebral lesion (Andersson lesion) as the first sign of disease in axial psoriatic arthritis","volume":"42","author":"Queiro","year":"2013","journal-title":"Scand J Rheumatol."},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0057","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2020.05.089","article-title":"Axial psoriatic arthritis: an update for dermatologists","volume":"84","author":"Gottlieb","year":"2021","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"10.1016\/j.semarthrit.2021.06.006_bib0058","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3899\/jrheum.200103","article-title":"It is high time that we define axial psoriatic arthritis","volume":"47","author":"Chandran","year":"2020","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2021.06.006_bib0059","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3899\/jrheum.090412","article-title":"Axial psoriatic arthritis: update on a longterm prospective study","volume":"36","author":"Chandran","year":"2009","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.06.006_bib0060","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3899\/jrheum.101049","article-title":"Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease","volume":"38","author":"Perez Alamino","year":"2011","journal-title":"J Rheumatol"},{"issue":"51","key":"10.1016\/j.semarthrit.2021.06.006_bib0061","doi-asserted-by":"crossref","first-page":"e5652","DOI":"10.1097\/MD.0000000000005652","article-title":"Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an Iberoamerican spondyloarthritis cohort","volume":"95","author":"Landi","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0062","first-page":"1","article-title":"Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis","volume":"16","author":"Gladman","year":"1993","journal-title":"Clin Invest Med."},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0063","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/BOR.0000000000000609","article-title":"Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?","volume":"31","author":"Chandran","year":"2019","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0064","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20971889","article-title":"Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?","volume":"12","author":"Benavent","year":"2020","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0065","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/rheumatology\/kez457","article-title":"Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?","volume":"59","author":"Feld","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0066","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2016.07.019","article-title":"Implications of the diversity of class I HLA associations in psoriatic arthritis","volume":"172","author":"Winchester","year":"2016","journal-title":"Clin Immunol."},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0067","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","article-title":"Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?","volume":"57","author":"Helliwell","year":"1998","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0068","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.1780140302","article-title":"Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. A comparative study","volume":"14","author":"McEwen","year":"1971","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0069","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.51.1.73","article-title":"The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study","volume":"51","author":"Salvarani","year":"1992","journal-title":"Ann Rheum Dis."},{"issue":"7","key":"10.1016\/j.semarthrit.2021.06.006_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ard.61.7.650","article-title":"The cervical spine in patients with psoriatic arthritis","volume":"61","author":"Laiho","year":"2002","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"10.1016\/j.semarthrit.2021.06.006_bib0071","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11926-009-0046-9","article-title":"Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis.","volume":"11","author":"Olivieri","year":"2009","journal-title":"Curr Rheumatol Rep."},{"issue":"10","key":"10.1016\/j.semarthrit.2021.06.006_bib0072","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/imt-2020-0045","article-title":"Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis","volume":"12","author":"Bieber","year":"2020","journal-title":"Immunotherapy"},{"issue":"8","key":"10.1016\/j.semarthrit.2021.06.006_bib0073","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3899\/jrheum.121433","article-title":"Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis","volume":"40","author":"Haddad","year":"2013","journal-title":"J Rheumatol."},{"issue":"12","key":"10.1016\/j.semarthrit.2021.06.006_bib0074","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41584-019-0294-7","article-title":"The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis","volume":"15","author":"Sieper","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0076","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0077","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.23789","article-title":"2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0078","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"9","key":"10.1016\/j.semarthrit.2021.06.006_bib0079","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.semarthrit.2021.06.006_bib0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","article-title":"Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis.","volume":"71","author":"Deodhar","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0081","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001149","article-title":"Effects of ustekinumab on spondylitis-associated endpoints in TNFi-na\u00efve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials","volume":"6","author":"Helliwell","year":"2020","journal-title":"RMD Open."},{"issue":"8","key":"10.1016\/j.semarthrit.2021.06.006_bib0082","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semarthrit.2021.06.006_bib0083","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.090215","article-title":"Established psoriatic arthritis: clinical aspects.","volume":"83","author":"Helliwell","year":"2009","journal-title":"J Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.semarthrit.2021.06.006_bib0084","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/ard.47.5.386","article-title":"Psoriatic spondyloarthropathy: a long term prospective study","volume":"47","author":"Hanly","year":"1988","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.semarthrit.2021.06.006_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s100670200003","article-title":"Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. a retrospective study.","volume":"21","author":"Queiro","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"7542","key":"10.1016\/j.semarthrit.2021.06.006_bib0086","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.332.7542.639","article-title":"Osteoarthritis","volume":"332","author":"Hunter","year":"2006","journal-title":"BMJ"},{"issue":"104","key":"10.1016\/j.semarthrit.2021.06.006_bib0087","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.1191","article-title":"Inflammation in intervertebral disc degeneration and regeneration","volume":"12","author":"Molinos","year":"2015","journal-title":"J R Soc Interface."},{"issue":"4","key":"10.1016\/j.semarthrit.2021.06.006_bib0088","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/BOR.0000000000000388","article-title":"a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment","volume":"29","author":"Mease","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2021.06.006_bib0089","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/acr.23693","article-title":"Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: a prospective cohort study","volume":"71","author":"H\u00f8jgaard","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-014-2734-8","article-title":"Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis","volume":"34","author":"K\u0131l\u0131\u00e7","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2021.06.006_bib0091","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.20421","article-title":"Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?","volume":"51","author":"Taylor","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:35Z","timestamp":1758733715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0049017221001190"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.006","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axial involvement in psoriatic arthritis: An update for rheumatologists","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}